On Friday, scPharmaceuticals Inc (NASDAQ: SCPH) opened lower -6.09% from the last session, before settling in for the closing price of $3.12. Price fluctuations for SCPH have ranged from $3.07 to $6.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -27.13% at the time writing. With a float of $34.09 million, this company’s outstanding shares have now reached $50.04 million.
In an organization with 136 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 69.55%, operating margin of -210.35%, and the pretax margin is -264.6%.
scPharmaceuticals Inc (SCPH) Insider Updates
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of scPharmaceuticals Inc is 31.88%, while institutional ownership is 65.11%. The most recent insider transaction that took place on Aug 13 ’24, was worth 2,000,000. In this transaction 10% Owner of this company bought 500,000 shares at a rate of $4.00, taking the stock ownership to the 5,806,670 shares.
scPharmaceuticals Inc (SCPH) Performance Highlights and Predictions
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.36 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -27.13% per share during the next fiscal year.
scPharmaceuticals Inc (NASDAQ: SCPH) Trading Performance Indicators
Check out the current performance indicators for scPharmaceuticals Inc (SCPH). In the past quarter, the stock posted a quick ratio of 6.89. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.84.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.91, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -0.95 in one year’s time.
Technical Analysis of scPharmaceuticals Inc (SCPH)
Let’s dig in a bit further. During the last 5-days, its volume was 1.15 million. That was better than the volume of 0.38 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 9.04%. Additionally, its Average True Range was 0.20.
During the past 100 days, scPharmaceuticals Inc’s (SCPH) raw stochastic average was set at 1.18%, which indicates a significant decrease from 2.37% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.04% in the past 14 days, which was lower than the 54.05% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $3.37, while its 200-day Moving Average is $4.07. However, in the short run, scPharmaceuticals Inc’s stock first resistance to watch stands at $3.18. Second resistance stands at $3.44. The third major resistance level sits at $3.57. If the price goes on to break the first support level at $2.79, it is likely to go to the next support level at $2.66. Assuming the price breaks the second support level, the third support level stands at $2.40.
scPharmaceuticals Inc (NASDAQ: SCPH) Key Stats
There are currently 50,040K shares outstanding in the company with a market cap of 146.62 million. Presently, the company’s annual sales total 13,590 K according to its annual income of -54,810 K. Last quarter, the company’s sales amounted to 10,030 K and its income totaled -35,110 K.
